Abiomed, Inc. (ABMD) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Abiomed, Inc., with annual and quarterly history.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 110.28x | 63.80x | 32.30x | 48.16x | 114.54x | 103.87x |
| P/B Ratio | 10.01x | 10.82x | 6.16x | 13.31x | 18.63x | 11.97x |
| P/S Ratio | 14.59x | 16.98x | 7.80x | 16.21x | 21.64x | 12.16x |
| Profitability | ||||||
| Gross Margin | 81.8% | 80.9% | 82.0% | 83.2% | 83.4% | 84.1% |
| Operating Margin | 36.1% | 27.1% | 29.6% | 29.2% | 26.5% | 20.2% |
| Net Margin | 13.2% | 26.6% | 24.1% | 33.7% | 18.9% | 11.7% |
| EBITDA Margin | 48.5% | 29.1% | 30.6% | 30.0% | 27.7% | 21.3% |
| Liquidity | ||||||
| Current Ratio | 7.05x | 6.11x | 4.82x | 6.39x | 5.84x | 4.70x |
| Quick Ratio | 6.37x | 5.48x | 4.14x | 5.63x | 5.24x | 4.19x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.04x |
YoY = year-over-year change. Source: FMP..